A significant finding involves HERV-W Env (Syncytin-1), which exhibits overexpression in 75.6% of bladder urothelial carcinomas (BUC) and demonstrates potential oncogenic properties. This evidence concerns the gene ERVW-1 and bladder transitional cell carcinoma.